
Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance
Author(s) -
Montserrat Estruch,
Camilla Vittori,
Teresa Muñoz Montesinos,
Kristian Reckzeh,
Kim TheilgaardMönch
Publication year - 2021
Language(s) - English
DOI - 10.20517/cdr.2021.76
Subject(s) - pi3k/akt/mtor pathway , myeloid leukemia , cancer research , chemotherapy , protein kinase b , dna repair , dna damage , medicine , leukemia , dna damage repair , myeloid , signal transduction , biology , immunology , dna , microbiology and biotechnology , genetics